Topic picture, symbol photo: Corona vaccine. Pfizer and BioNTech Announce Successful First Interim Analysis of their COVID-19 Vaccine Candidate in Current Phase 3 Trial A hand wrapped in rubber gloves holds a disposable syringe of vaccine for injection in a needle BIONTECH biotechnology company. | usage worldwide
Germany’s COVID-19 vaccination campaign has been overshadowed by a mishap in the north where eight workers in an elderly care home received an overdose.
Vorpommern-Ruegen district authorities said the workers in Stralsund city received five times the recommended dose of the BioNTech-Pfizer vaccine on Sunday. Four went to the hospital for observation after developing flu-like symptoms.
“I deeply regret the incident. This individual case is due to individual errors. I hope that all those affected do not experience any serious side-effects,” district chief Stefan Kerth said in a statement.
The incident came after some German districts declined to use vaccines received over the weekend on suspicion that cold conditions were interrupted during delivery.
Vorpommern-Ruegen authorities pointed to previous statements by BioNtech saying larger doses were tested in the Phase 1 study without serious consequences. There was no immediate comment from the pharmaceutical companies.
(Reuters)
A joint working session took place this Thursday evening at the headquarters of the Ministry…
A specialized brigade of the National Guard in Sousse was able to apprehend a woman…
The Center for Research in Astronomy, Astrophysics and Geophysics in Algeria registeredthis evening, Thursday, May…
A citizen from the town of Al Kalaa Kobra confirmed that his mother was surprised…
Palestinian President Mahmoud Abbas accused, in his address today before the Arab summit in Manama,…
Palestinian President Mahmoud Abbas stated that American support for Israel "calls into question international legitimacy…
This website uses cookies.